Over 140 million people in 70 countries drink arsenic-contaminated water, killing tens of thousands annually. AquAffirm has developed the simple, quick, reliable, digital field test for arsenic which is web-enabled. With an experienced successful founder team, AquAffirm is commercialising a rapid low-cost, easy-to-use disposable strip to measure concentrations of toxins in water, starting with arsenic.
Results will be digitally-analysed and GPS-/web-enabled to facilitate mapping of contamination hot-spots. The team is already selling the base electrode (manufactured in batches of 4,000x) into the research market.
AquAffirm is seeking £1 million funding in this investment round (EIS advance assurance has been received from HMRC). The Directors reserve the right to increase the size of the Offer at their discretion.
The value of AquAffirm’s shares may go up or down. As these shares have no readily available market, they may be difficult to sell.
The Enterprise Investment Scheme offers a series of tax reliefs to UK tax payers. It is designed to encourage investment in small unquoted companies carrying on an EIS qualifying trade in the United Kingdom. Eligibility for these tax reliefs is dependent on the circumstances of the individual investor.
Income Tax Relief
Individuals can obtain 30% income tax relief on EIS investments up to £2,000,000 in the current tax year, providing that at least £1,000,000 is in HMRC defined knowledge-intensive company.
Exemption from Capital Gains Tax
No CGT is payable on gains realised on the disposal of the Investments provided that they have been held for at least three years from the date of investment (or from the date of commencement of the Investee Company’s trade if later).
Capital Gains Deferral
Individuals can defer CGT on chargeable gains by making an investment of an amount equivalent to the chargeable gain in EIS qualifying shares.
Capital losses realised from an investment in EIS qualifying shares may qualify for share loss relief (net of income tax relief). The loss may be set against the individual’s taxable income, or the loss may be offset against capital gains in the tax year of disposal. Any excess losses may be carried forward for relief against future capital gains.
Investment in our products exposes your capital to risk. Amberside Capital does not provide investment, tax or legal advice and the details contained in this website is for your information only. We strongly recommend you seek professional advice if you are considering investing with us. You may lose all or part of your capital invested.
Amberside Capital invests in unlisted shares in small companies. The value of these shares may go up or down. As these shares have no readily available market, they may be difficult to sell.
The tax reliefs associated with our investments depend on each individual investor’s circumstances and may be subject to change. Past performance is not a reliable indicator of how your investments may perform in the future and as such, performance information should not be treated as guarantee.
Fill out form below to contact us directly.